Skip to main content
. Author manuscript; available in PMC: 2023 Nov 20.
Published in final edited form as: Clin Pharmacokinet. 2023 Sep 21;62(11):1611–1619. doi: 10.1007/s40262-023-01307-6

Table 3.

Pediatric physiologically based pharmacokinetic model-predicted versus observed AUC 0-τa

Study 5-mg/kg/day target dose 10-mg/kg/day target dose 20-mg/kg/day target dose

Day 1 at 1.25 mg/kg
Devinsky et al. [13] 70.6 (20.4) (N = 10) 66.4 (121) (N = 8) 73.7 (96.6) (N = 9)
This study 76.5 (59.4) 76.5 (59.4) 76.5 (59.4)
Day 22 at target dose via BID
Devinsky et al. [13] 241 (101) (N = 10) 722 (79.9) (N = 8) 963 (93.4) (N = 9)
This study 207 (64.6) 401 (60.0) 748 (57.3)

AUC area under the curve, BID twice daily, N number of patients

a

τ: 5 hours, AUC0τ presented as a geometric mean in ng⋅h/mL (% coefficient of variation)